FDA's claims over stem cells upheld
- PMID: 22859178
- DOI: 10.1038/488014a
FDA's claims over stem cells upheld
Similar articles
-
FDA challenges stem-cell clinic.Nature. 2010 Aug 19;466(7309):909. doi: 10.1038/466909a. Nature. 2010. PMID: 20725009 No abstract available.
-
The US Direct-to-Consumer Marketplace for Autologous Stem Cell Interventions.Perspect Biol Med. 2018;61(1):7-24. doi: 10.1353/pbm.2018.0024. Perspect Biol Med. 2018. PMID: 29805145 Review.
-
The Food and Drug Administration, regenerative sciences, and the regulation of autologous stem cell therapies.Food Drug Law J. 2011;66(4):479-506, i. Food Drug Law J. 2011. PMID: 24505826
-
Rejuvenating Regenerative Medicine Regulation.N Engl J Med. 2018 Feb 8;378(6):504-505. doi: 10.1056/NEJMp1715736. Epub 2018 Jan 10. N Engl J Med. 2018. PMID: 29320637 No abstract available.
-
A question of ethics: selling autologous stem cell therapies flaunts professional standards.Stem Cell Res. 2014 Nov;13(3 Pt B):647-53. doi: 10.1016/j.scr.2014.04.014. Epub 2014 Apr 29. Stem Cell Res. 2014. PMID: 24857592 Review.
Cited by
-
Call for fellowship programs in stem cell-based regenerative and cellular medicine: new stem cell training is essential for physicians.Regen Med. 2013 Mar;8(2):223-5. doi: 10.2217/rme.13.1. Regen Med. 2013. PMID: 23477401 Free PMC article.
-
Stem cell/cellular interventions in human spinal cord injury: Is it time to move from guidelines to regulations and legislations? Literature review and Spinal Cord Society position statement.Eur Spine J. 2019 Aug;28(8):1837-1845. doi: 10.1007/s00586-019-06003-3. Epub 2019 May 16. Eur Spine J. 2019. PMID: 31098715 Review.
-
Concise review: workshop review: understanding and assessing the risks of stem cell-based therapies.Stem Cells Transl Med. 2015 Apr;4(4):389-400. doi: 10.5966/sctm.2014-0110. Epub 2015 Feb 26. Stem Cells Transl Med. 2015. PMID: 25722427 Free PMC article. Review.
-
The Effect of Early Rounds of ex vivo Expansion and Cryopreservation on the Adipogenic Differentiation Capacity of Adipose-Derived Stromal/Stem Cells.Sci Rep. 2019 Nov 4;9(1):15943. doi: 10.1038/s41598-019-52086-9. Sci Rep. 2019. PMID: 31685852 Free PMC article.
-
Improved MSC Minimal Criteria to Maximize Patient Safety: A Call to Embrace Tissue Factor and Hemocompatibility Assessment of MSC Products.Stem Cells Transl Med. 2022 Mar 3;11(1):2-13. doi: 10.1093/stcltm/szab005. Stem Cells Transl Med. 2022. PMID: 35641163 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical